29.12.2021 Views

Diagnostic ultrasound ( PDFDrive )

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

688 PART II Abdominal and Pelvic Sonography

by deinition involves three main sites—the central nervous

system, solid organs, or the gastrointestinal tract. he liver is

the most common site of intraabdominal involvement, occurring

in 30% to 45% of patients with PTLD. In rare cases, intraosseous

lesions may be present, with imaging features on CT

and MRI similar to those of metastatic disease, infection, or

primary bone lymphoma. Overall, PTLD should be considered

in the diferential diagnosis of any transplant patient with

lymphadenopathy or a new lesion within a solid viscus or the

skeletal system. 107-110

When the solid organs are involved, there are four main

patterns of disease:

1. Iniltrative pattern: here is an ill-deined mass or masses

that are extrinsic to the hilum and can result in secondary

mass efect and/or vascular compromise. For instance, within

the liver it may cause biliary obstruction and obstruction of

blood low within the periportal space. In renal involvement

the mass typically is located extrinsic to the renal pelvis with

resultant mass efect and obstruction of the vessels and the

collecting system. In both instances the mass is usually relatively

hypoenhancing but luorodeoxyglucose (FDG) avid on

positron emission tomography (PET) imaging.

2. Parenchymal pattern: his is characterized by multiple lesions

that are disseminated throughout the afected organ. hese

also tend to be hypoenhancing. In the lung they are typically

solid and may rarely cavitate. here may also be ill-deined

alveolar iniltrates.

3. Solitary mass: A solitary mass in the afected organ is

seen on ultrasound as a hypoechoic lesion with no Doppler

signal on color Doppler imaging. Calciication is unusual but

seen in the context of posttreatment changes or tumor

necrosis.

4. Iniltrative lesion: his lesion involves the organ in question

but also extends to involve regional structures such

as the chest, abdominal wall, and adjacent solid organs.

As a secondary manifestation, there may be dysfunction

of the other organ(s) that are involved. Pancreatic PTLD

tends to produce difuse glandular enlargement, with an

appearance that is indistinguishable from pancreatitis or

rejection. 111

Gastrointestinal disease can involve either bowel or the

peritoneal cavity. When there is peritoneal disease, it can be

nodular or difusely iniltrating. 112 PTLD involving the gastrointestinal

tract is seen in association with mural thickening,

aneurysmal dilatation, ulceration, intussusception, and polypoidal

lesions. Perforation is a rare manifestation of intestinal PTLD;

the decline in perforation rates has been attributed to improved

diagnosis and treatment of PTLD. As with any other

lymphomatous-type lesions of the gut, obstruction of the bowel

segments is rare.

Treatment Options

Stratiication and patient management are determined by the

subtype of PTLD, the distribution of disease, and the type of

allograt. Potential management options include modiication

of immunosuppression, chemotherapy, radiation, and rituximab

therapy as well as surgical resection of isolated lesions. Rituximab

is a monoclonal antibody against B cell receptors, has a low

toxicity proile, and has a response rate on the order of 60%.

Preservation of grat function is an important goal of management

while treating the PTLD. 113,114

PET-CT has a pivotal role to play in monitoring response to

therapy, particularly in patients in whom there are persistent

focal lesions. In this scenario, FDG uptake allows discrimination

between residual tumor and ibrosis.

REFERENCES

1. Takemoto S, Terasaki PI, Cecka JM, et al. Survival of nationally shared,

HLA-matched kidney transplants from cadaveric donors. he UNOS Scientiic

Renal Transplant Registry. N Engl J Med. 1992;327(12):834-839.

2. Berthoux FC, Jones EH, Mehls O, Valderrabano F. Transplantation report.

1: Renal transplantation in recipients aged 60 years or older at time of

grating. he EDTA-ERA Registry. European Dialysis and Transplant

Association–European Renal Association. Nephrol Dial Transplant.

1996;11(Suppl. 1):37-40.

3. Cattral MS, Bigam DL, Hemming AW, et al. Portal venous and enteric

exocrine drainage versus systemic venous and bladder exocrine drainage

of pancreas grats: clinical outcome of 40 consecutive transplant recipients.

Ann Surg. 2000;232(5):688-695.

4. United Network for Organ Sharing. National data. Transplants by organ

type January 1, 1988–June 30, 2016. Available from: https://www.unos.org/

data. Accessed 2016 July 18.

5. Crossin JD, Muradali D, Wilson SR. US of liver transplants: normal and

abnormal. Radiographics. 2003;23(5):1093-1114.

6. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment

of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med.

1996;334(11):693-699.

7. Quiroga S, Sebastia MC, Margarit C, et al. Complications of orthotopic

liver transplantation: spectrum of indings with helical CT. Radiographics.

2001;21(5):1085-1102.

8. Nghiem HV. Imaging of hepatic transplantation. Radiol Clin North Am.

1998;36(2):429-443.

9. Kamel IR, Kruskal JB, Raptopoulos V. Imaging for right lobe living donor

liver transplantation. Semin Liver Dis. 2001;21(2):271-282.

10. Wolfsen HC, Porayko MK, Hughes RH, et al. Role of endoscopic retrograde

cholangiopancreatography ater orthotopic liver transplantation. Am J

Gastroenterol. 1992;87(8):955-960.

11. Keogan MT, McDermott VG, Price SK, et al. he role of imaging in the

diagnosis and management of biliary complications ater liver transplantation.

AJR Am J Roentgenol. 1999;173(1):215-219.

12. Letourneau JG, Castaneda-Zuniga WR. he role of radiology in the diagnosis

and treatment of biliary complications ater liver transplantation. Cardiovasc

Intervent Radiol. 1990;13(4):278-282.

13. Barton P, Maier A, Steininger R, et al. Biliary sludge ater liver transplantation:

1. Imaging indings and eicacy of various imaging procedures. AJR Am

J Roentgenol. 1995;164(4):859-864.

14. Miller WJ, Campbell WL, Zajko AB, et al. Obstructive dilatation of extrahepatic

recipient and donor bile ducts complicating orthotopic liver

transplantation: imaging and laboratory indings. AJR Am J Roentgenol.

1991;157(1):29-32.

15. Zajko AB, Campbell WL, Bron KM, et al. Cholangiography and interventional

biliary radiology in adult liver transplantation. AJR Am J Roentgenol.

1985;144(1):127-133.

16. Sheng R, Zajko AB, Campbell WL, Abu-Elmagd K. Biliary strictures in

hepatic transplants: prevalence and types in patients with primary sclerosing

cholangitis vs those with other liver diseases. AJR Am J Roentgenol.

1993;161(2):297-300.

17. Ward EM, Wiesner RH, Hughes RW, Krom RA. Persistent bile leak

ater liver transplantation: biloma drainage and endoscopic retrograde

cholangiopancreatographic sphincterotomy. Radiology. 1991;179(3):719-

720.

18. McDonald V, Matalon TA, Patel SK, et al. Biliary strictures in hepatic

transplantation. J Vasc Interv Radiol. 1991;2(4):533-538.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!